Ironwood Pharmaceuticals, Inc. (IRWD)
3.175
-0.02
(-0.47%)
USD |
NASDAQ |
Mar 26, 14:11
Ironwood Pharmaceuticals Cash from Investing (Quarterly) : 0.001M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -1.463B |
| Outlook Therapeutics, Inc. | 0.00 |
| Nektar Therapeutics | 0.372M |
| Rigel Pharmaceuticals, Inc. | -25.36M |
| Recursion Pharmaceuticals, Inc. | -1.244M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 74.58M |
| Cash from Financing (Quarterly) | 0.122M |
| Free Cash Flow | 127.01M |
| Free Cash Flow Per Share (Quarterly) | 0.4591 |
| Free Cash Flow to Equity (Quarterly) | 75.01M |
| Free Cash Flow to Firm (Quarterly) | 35.13M |
| Free Cash Flow Yield | 23.60% |